Aspirin, NOACs, warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.
作者信息
Mone Pasquale, Trimarco Bruno, Santulli Gaetano
机构信息
Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY, USA.
ASL (Azienda Sanitaria Locale-Local Health Unit) AV, Avellino, Italy.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E7-E8. doi: 10.1093/ehjcvp/pvab081.
Abstract
摘要
相似文献
1
Aspirin, NOACs, warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):E7-E8. doi: 10.1093/ehjcvp/pvab081.
2
Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.抗凝治疗对非瓣膜性心房颤动患者认知功能下降和痴呆影响的研究（CAF）的理由和设计：一项先锋研究。
Clin Cardiol. 2019 May;42(5):506-512. doi: 10.1002/clc.23181. Epub 2019 Apr 10.
3
Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.非维生素 K 拮抗剂口服抗凝剂与华法林在心房颤动患者中的比较及与痴呆的关系：一项全国性倾向评分匹配队列研究。
J Am Heart Assoc. 2019 Jun 4;8(11):e011358. doi: 10.1161/JAHA.118.011358. Epub 2019 May 29.
4
Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial.达比加群酯与华法林对老年心房颤动患者 2 年认知结局的影响：来自 GIRAF 随机临床试验的结果。
BMC Med. 2022 Oct 26;20(1):374. doi: 10.1186/s12916-022-02563-2.
5
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.华法林与四种非维生素K拮抗剂口服抗凝剂用于卒中二级预防时的复发卒中量及预后分析
J Stroke Cerebrovasc Dis. 2018 Feb;27(2):338-345. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.007. Epub 2017 Oct 13.
6
7
Efficacy and Safety of Oral Anticoagulants in Older Adult Patients With Atrial Fibrillation: Pairwise and Network Meta-Analyses.口服抗凝剂在老年房颤患者中的疗效和安全性：成对和网络荟萃分析。
J Am Med Dir Assoc. 2023 Aug;24(8):1233-1239.e26. doi: 10.1016/j.jamda.2023.05.010. Epub 2023 Jun 22.
8
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.非维生素K拮抗剂口服抗凝剂阿哌沙班、达比加群和利伐沙班在静脉血栓栓塞症长期治疗和预防中的比较：系统评价与网状Meta分析
PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016.
9
Comparative risk for intracranial hemorrhage related to new oral anticoagulants: A network meta-analysis.新型口服抗凝剂相关颅内出血的比较风险：一项网状Meta分析。
Medicine (Baltimore). 2021 Mar 26;100(12):e24522. doi: 10.1097/MD.0000000000024522.
10
Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.行房颤消融术患者中中断或不中断口服抗凝治疗。
Cardiovasc Drugs Ther. 2020 Jun;34(3):371-381. doi: 10.1007/s10557-020-06967-1.
引用本文的文献
1
Warfarin Versus Non-Vitamin K Inhibitor Medications and Cognitive Disease Progression in Atrial Fibrillation.华法林与非维生素K拮抗剂类药物及心房颤动患者的认知疾病进展
J Cardiovasc Nurs. 2024 Dec 30. doi: 10.1097/JCN.0000000000001159.
2
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy.观察性研究：老年非瓣膜性心房颤动接受抗凝治疗患者的衰弱情况。
Sci Rep. 2024 Jun 22;14(1):14423. doi: 10.1038/s41598-024-65237-4.
3
Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (cognitive decline and dementia in patients with non-valvular atrial fibrillation [CAF] trial).抗凝治疗对非瓣膜性心房颤动患者认知功能减退和痴呆的影响（非瓣膜性心房颤动患者认知功能减退和痴呆[CAF]试验）
J Arrhythm. 2022 Sep 19;38(6):997-1008. doi: 10.1002/joa3.12781. eCollection 2022 Dec.
4
Water-Soluble Tomato Concentrate, a Potential Antioxidant Supplement, Can Attenuate Platelet Apoptosis and Oxidative Stress in Healthy Middle-Aged and Elderly Adults: A Randomized, Double-Blinded, Crossover Clinical Trial.水溶性番茄浓缩物，一种有潜力的抗氧化补充剂，可以减轻健康中年和老年人的血小板凋亡和氧化应激：一项随机、双盲、交叉临床试验。
Nutrients. 2022 Aug 17;14(16):3374. doi: 10.3390/nu14163374.
本文引用的文献
1
Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia.衰弱的老年高血压患者的认知障碍：高血糖的作用。
Cells. 2021 Aug 17;10(8):2115. doi: 10.3390/cells10082115.
2
Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement.老年人认知障碍筛查：美国预防服务工作组推荐声明。
JAMA. 2020 Feb 25;323(8):757-763. doi: 10.1001/jama.2020.0435.
3
In diabetes with no CVD, aspirin reduced serious vascular events but increased major bleeding at 7.4 years.在无心血管疾病的糖尿病患者中，阿司匹林在7.4年时可减少严重血管事件，但会增加大出血风险。
Ann Intern Med. 2018 Dec 18;169(12):JC67. doi: 10.7326/ACPJC-2018-169-12-067.
4
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.阿司匹林用于糖尿病患者一级预防的效果。
N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26.
Zotero 插件